The Skolkovo Foundation has signed a cooperation agreement with Janssen, a Belgium-headquartered subdivision of U.S. pharma giant Johnson & Johnson, with the aim of boosting innovative pharmaceutical research, including through financial support. Priority...
Half of all Russian-origin innovative pharmaceuticals are developed by Skolkovo Foundation startups, Kirill Kaem, head of the organisation’s biomed cluster, told a meeting of the foundation’s council on Monday evening. Of about 1,400 pharmaceuticals...
The Skolkovo Foundation has signed a cooperation agreement with BioCubaFarma, Cuba’s biggest biotech company, continuing a series of agreements and mutual visits between the foundation and the island nation. Prime Minister Dmitry Medvedev, right...
Skolkovo’s Biomed Cluster is expecting around 30 to 40 agriculture-based startups to become residents in the coming months as the Russian government moves to encourage high-tech innovation in food production. Skolkovo VP Kirill Kaem, the executive...
The Skolkovo Foundation is stepping up its efforts in the fight against cancer by putting its biomedical startups at the disposal of the oncological community. Skolkovo VP Kirill Kaem, left, exchanging agreements with Sergei Tyulyandin in Moscow. Photo...